Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses: 2017-2025

Historic Interest Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to -$415,000.

  • Organogenesis Holdings' Interest Expenses fell 188.11% to -$415,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 199.95%. This contributed to the annual value of $1.5 million for FY2024, which is 29.50% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Interest Expenses of -$415,000 as of Q3 2025, which was up 37.97% from -$669,000 recorded in Q2 2025.
  • Organogenesis Holdings' Interest Expenses' 5-year high stood at $2.5 million during Q1 2021, with a 5-year trough of -$961,000 in Q1 2025.
  • In the last 3 years, Organogenesis Holdings' Interest Expenses had a median value of $471,000 in 2024 and averaged $153,455.
  • As far as peak fluctuations go, Organogenesis Holdings' Interest Expenses soared by 1,773.33% in 2023, and later tumbled by 286.96% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Interest Expenses (Quarterly) stood at $853,000 in 2021, then plummeted by 103.52% to -$30,000 in 2022, then skyrocketed by 1,773.33% to $502,000 in 2023, then tumbled by 112.15% to -$61,000 in 2024, then tumbled by 188.11% to -$415,000 in 2025.
  • Its Interest Expenses stands at -$415,000 for Q3 2025, versus -$669,000 for Q2 2025 and -$961,000 for Q1 2025.